176 related articles for article (PubMed ID: 33645041)
1. [Communication in process of R&D and registration of new drugs of traditional Chinese medicine].
Han L; Hou CC
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):730-735. PubMed ID: 33645041
[TBL] [Abstract][Full Text] [Related]
2. [Thoughts and suggestions on registration and classification of traditional Chinese medicines].
Tang JY
Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(16):4004-4008. PubMed ID: 32893601
[TBL] [Abstract][Full Text] [Related]
3. Future development of global regulations of Chinese herbal products.
Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation for druggability of traditional Chinese medicine preparations in medical institutions based on human use experience].
Zhuo JX; Qiu ZW; Zhou J; Wu YM; Yang ML; Yang ZQ
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4256-4260. PubMed ID: 36046916
[TBL] [Abstract][Full Text] [Related]
5. [How to adapt to the requirements of "clinical value-oriented drug innovation" for pharmaceutical research in application process of new traditional Chinese medicine].
Jin F
Zhongguo Zhong Yao Za Zhi; 2017 May; 42(9):1797-1802. PubMed ID: 29082710
[TBL] [Abstract][Full Text] [Related]
6. [Consideration about chemistry, manufacture and control (CMC) key problems in simplified registration of classical traditional Chinese medicine excellent prescriptions].
Wang ZM; Liu JY; Liu XQ; Wang DQ; Yan LH; Zhu JJ; Gao HM; Li C; Wang JY; Li CY; Ni QC; Huang JS; Lin J
Zhongguo Zhong Yao Za Zhi; 2017 May; 42(10):1819-1824. PubMed ID: 29090536
[TBL] [Abstract][Full Text] [Related]
7. [Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].
Ai YL; Tang JY; Zhou G; Zhang L; Qu LP; Huang SY; Yang ZQ; Yuan WA; Zhou YH; Wang T; Zhao JN; Sun XB; Xiao XH; Yang ZF; Liu QQ; Zhu MJ; Leng XY; Xie CG; Chai SY
Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):1120-1125. PubMed ID: 35285213
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on reasons for disapproval of registration application of new traditional Chinese medicines in recent years].
Zhang X; Zhang L; Wang H
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2333-7. PubMed ID: 23193572
[TBL] [Abstract][Full Text] [Related]
9. [Pharmaceutical changes and countermeasures for transformation of traditional Chinese medicine preparations in medical institutions into new drugs based on human use experience].
Liu DH; He XL; Ni SH; Tang YQ; Tang HM; Lu L; Yang ZQ
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):565-568. PubMed ID: 38403331
[TBL] [Abstract][Full Text] [Related]
10. [Scientific supervision of compound preparation of traditional Chinese medicine and chemical drug].
Yu J; Yu B; Qian Z
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1542-6. PubMed ID: 22779196
[TBL] [Abstract][Full Text] [Related]
11. [Discovery, research and development for innovative drug of traditional Chinese medicine under new situations].
Tu PF; Jiang Y; Guo XY
Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3423-8. PubMed ID: 26978984
[TBL] [Abstract][Full Text] [Related]
12. [Category of Chinese medicine registration:historical evolution,current status,and problems].
Qu LP; Tang JY; Zhang L; Yang ZQ; Yuan WA; Wang T; Zhang YW; Li G
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):562-568. PubMed ID: 35179001
[TBL] [Abstract][Full Text] [Related]
13. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
[TBL] [Abstract][Full Text] [Related]
14. [Research and development of new traditional Chinese medicine drugs for certain syndromes based on "theoretical innovation"].
Lian MA; Ke-Bin W; Sheng-Xian WU
Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):5048-5056. PubMed ID: 33350282
[TBL] [Abstract][Full Text] [Related]
15. [Application of real world study and human use experience in research and development of new traditional Chinese medicine drugs].
Yang ZQ; Tang HM; Tang YQ; DU YP; Gao R; Hu SY; Yuan WA; Zou C; Ding H; Zhao YL
Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(22):5987-5991. PubMed ID: 34951190
[TBL] [Abstract][Full Text] [Related]
16. [Opportunities and challenges in development of compound preparations of traditional Chinese medicine: problems and countermeasures in research of ancient classical prescriptions].
Zhang Q; Han XX; Mao CQ; Xie H; Chen LH; Mao J; Lu TL; Yan GJ
Zhongguo Zhong Yao Za Zhi; 2019 Oct; 44(19):4300-4308. PubMed ID: 31872713
[TBL] [Abstract][Full Text] [Related]
17. [Status, problems and warranty strategy of quality uniformity for traditional Chinese medicine preparations].
Zeng LH; Wu ZF; Wang F; Wang XC; Wang YQ; Yue PF; Wan N; Lin HY; Yang M
Zhongguo Zhong Yao Za Zhi; 2017 Oct; 42(19):3826-3830. PubMed ID: 29235302
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation on review quality management and progress and suggestions of reform in traditional Chinese medicine review].
An N; Han L
Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(22):5999-6003. PubMed ID: 34951192
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of innovative drug category 1.2 in traditional Chinese medicine and considerations on quality control of extracts].
Zhao XX
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2601-2606. PubMed ID: 34047109
[TBL] [Abstract][Full Text] [Related]
20. [Consensus on collaborative ethical review of multi-center clinical trials of new drugs of traditional Chinese medicine (version 1.0)].
Zou C; Ding H; Gao R; Hu SY; Liu JZ; Li B; Li XH; Pan DJ; Tang JY; Tong XY; Wang JY; Yuan WA; Zhang X; Zhang M; Zhao YL; Yang ZQ
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1696-1700. PubMed ID: 33982471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
